Yes, doneWould it make sense to sticky this megathread in the resources section so it doesn’t get lost & stale, @Hutan?
Yes, doneWould it make sense to sticky this megathread in the resources section so it doesn’t get lost & stale, @Hutan?
When is the deadline?
I agree with this.In an interim situation physicians can set up publishable studies, as I did. Using something like daratumumab is not simple. You have to know about plasma cells, otherwise you get the situation we got with rituximab with a mass of uninformed French physicians making the patients hypogammaglobulinaemic so that they got infections. Use of dara should probably be restricted to physicians with good understanding of immunology at least until a formal license is out and I would tend to argue, even after.
I was assuming that there will be at least some private immunologists/rheumatologists who begin providing dara if it is successful in phase 2.I agree with this.
Patients must not let our desperation cloud our judgement and caution. Most long-termers have made that mistake, including me.
Unfortunately it is still being made by some patient support groups and 'patient-led' research.
I was thinking about being more specific about what therapeutic enthusiasms patients and carers need protecting from (diaries etc.).
Oh my God, yes. Thanks for highlighting that. One of the reasons I think those who are on income support benefits need to have their 3 monthly reviews changed to 2 yearly as quickly as possible after ME/CFS has been diagnosed because as you described so well above with 3 weeks is nothing, '3 months is nothing' as well.I was given more time but again, no one seems to understand that 3 weeks is nothing when you are so ill.
what happened to Nurses for ME?If nurses were involved perhaps it could be recognized by the Royal college of nursing making it an official document.
what happened to Nurses for ME?
I’m thinking that it might be helpful if the DHSC and the MRC were able to give some sort assurance that such trials would be funded provided the necessary thresholds are met to justify a trial.
This is a great ideaI also think Fluge and Mella’s approach to testing drugs for ME/CFS could be highlighted as an example of how things should be done.
Are we allowed to know who is in the FME service subgroup?
Agree. In my experience and what I’ve seen from other conditions those best able to help people navigate the system, remove obstacles, etc. are specialist nurses.I think there should be specialist nurses as the main point of contact for patients, providing a range of ways to communicate including online, phone and home visits.
“Should” is doing a lot of heavy lifting there. Who decides if someone is good? Who decides if the idea is good? The same people who have decided not to fund SequenceME? I’m just wondering whether the DHSC could give a more concrete assurance – perhaps specifying certain thresholds. I know you’re not a fan of ring-fencing, but maybe they set up a fund so that researchers can have confidence that the money is there.We already have assurances like that but of course they are as long as a piece of string. I don't see any way of bucking the system. If someone good has a good idea for a trial they should be able to set it up.
Will we be allowed to know what FME has recommended to the DHSC, and which organisations and individuals support it?
Yes. Yes. Yes.Already been said, but it's worth underlining: the main objective for the nurses is to help stop people getting worse, not to make them better.
ResetME (dara p2/3) has received no public funding.If F&M were in the UK I’m not at all confident they would have got MRC funding for their trials. I’m not even confident that physicians in their position would have bothered applying to the MRC, such has been its history with ME/CFS.
I’m just wondering whether the DHSC could give a more concrete assurance – perhaps specifying certain thresholds.
It has to be based on reality and politics.